Phathom Pharmaceuticals, Inc. PHAT Net Investment in Lease
Net Investment in Lease at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s net investment in lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s net investment in lease?
- Phathom Pharmaceuticals, Inc. (PHAT) reported net investment in lease of $2.51M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s net investment in lease changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s net investment in lease increased by 546.4% year-over-year, from $388K to $2.51M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s net investment in lease?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s net investment in lease has grown at a 1.9% compound annual growth rate (CAGR), from $2.37M to $2.6M.